California Pacific Medical Center Drug Shipment (2) — San Francisco, California

California Pacific Medical Center Drug Shipment (2) is a clinical research site located in San Francisco, California, United States 94120-7999.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

California Pacific Medical Center Drug Shipment (2) has participated in 1 clinical trials.

Therapeutic areas: Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Francisco

Browse all research sites in California · View every site in San Francisco

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for California Pacific Medical Center Drug Shipment (2)?

California Pacific Medical Center Drug Shipment (2) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has California Pacific Medical Center Drug Shipment (2) conducted?

California Pacific Medical Center Drug Shipment (2) has 1 clinical trials on record. Their work covers Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma.

Is California Pacific Medical Center Drug Shipment (2) accredited by Crixeo Clinical Trials?

California Pacific Medical Center Drug Shipment (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about California Pacific Medical Center Drug Shipment (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.